|
|
||||||||
From the Department of Neurology (Drs. Bigal and Lipton), Albert Einstein College of Medicine, Bronx, NY, New England Center for Headache (Drs. Bigal, Rapoport, Sheftell, and Tepper), Stamford, CT, Montefiore Headache Clinic (Drs. Bigal and Lipton), Bronx, NY, Department of Neurology (Dr. Rapoport), Columbia University College of Physicians and Surgeons, New York, NY, Department of Psychiatry (Dr. Sheftell), New York Medical College, New York, Department of Neurology (Dr. Tepper), Yale University School of Medicine, New Haven, CT, and Department of Epidemiology and Population Health (Dr. Lipton), Albert Einstein College of Medicine, Bronx, NY.
Address correspondence and reprint requests to Dr Bigal, 1165 Morris Park Ave., Rousso Bldg., Office 334-A, Bronx, NY, 10461; e-mail: mbigal{at}aecom.yu.edu
Background: Chronic migraine (CM) is characterized by 15 or more migraine days per month. Most adults with chronic daily headache (CDH) that evolved from migraine have <15 days of migraine/month. They are often classified as transformed migraine (TM), a disorder not addressed in the International Headache Society classification.
Objective: To test the hypothesis that early in the course of migraine chronification, the frequency of migraine attacks is high and that as illness progresses the frequency of nonmigraine headaches increases.
Methods: Information was collected on 402 adults with TM and was divided into two groups. Group 1 TM had
15 days of migraine/month, whereas Group 2 TM had <15 days of migraine/month. Risk factors were modeled for number of migraine days per month using logistic regression.
Results: Of 402 subjects with TM, 121 (30.1%) were in Group 1. The proportion of Group 1 subjects decreased with age, from 71% below age 30 to 22% age 60 or above. The correspondent proportion of Group 2 increased from 29 to 78%. More than 15 days of migraine per month was independently predicted by younger ages (<40 years; p = 0.002), shorter interval from episodic to CDH (<5 years; p = 0.003), and shorter time since the development of CDH (<6 years; p < 0.0001).
Conclusion: Chronic migraine is an earlier stage of transformed migraine.
Disclosure: The authors report no conflicts of interest.
Received March 8, 2005. Accepted in final form July 20, 2005.
Related Article
Neurology 2005 65: 1518-1519.
This article has been cited by other articles:
![]() |
S.-J. Wang, J.-L. Fuh, and S.-R. Lu Chronic daily headache in adolescents: An 8-year follow-up study Neurology, August 11, 2009; 73(6): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bigal, S. Ashina, R. Burstein, M. L. Reed, D. Buse, D. Serrano, R. B. Lipton, and On behalf of the AMPP Group Prevalence and characteristics of allodynia in headache sufferers: A population study Neurology, April 22, 2008; 70(17): 1525 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Wang, J.-L. Fuh, S.-R. Lu, and K.-D. Juang Outcomes and predictors of chronic daily headache in adolescents: A 2-year longitudinal study Neurology, February 20, 2007; 68(8): 591 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Gerwin and D. W. Dodick Chronic daily headache. N. Engl. J. Med., May 4, 2006; 354(18): 1958 - 1958. [Full Text] [PDF] |
||||
![]() |
S-J Wang, J-F Lirng, J-L Fuh, and J-J Chen Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 622 - 625. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |